what is a glp-1 antagonist Frontiers Glucagon-like peptide 1 receptor agonists:

The degree of weight gain varies, with some regaining more than others, while many can preserve their progress through ongoing healthy choices

The rapid expansion of this drug class since 2005 reflects growing recognition that managing blood sugar and body weight requires sophisticated, multi system approaches rather than single organ treatments

Daniel Drucker, MD, then a postdoctoral fellow in the Habener lab, characterized the enzymatic activity of GLP-1, while Jens Juul Holst, MD, at the University of Copehagen, simulatenously discovered GLP-1 regulated insulin secretion

These findings underscore the translational relevance of rodent models and highlight potential species-specific differences, particularly in cortical GLP-1R expression relevant to executive function and craving control [25]

With orforglipron, participants maintained 79.3% of their earlier weight loss, compared with 37.6% in the placebo cohort